• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
[Effect of danusertib on cell cycle, apoptosis and autophagy of hepatocellular carcinoma HepG2 cells ].达纳唑替尼对肝癌HepG2细胞周期、凋亡及自噬的影响
Nan Fang Yi Ke Da Xue Xue Bao. 2018 Dec 30;38(12):1476-1484. doi: 10.12122/j.issn.1673-4254.2018.12.13.
2
The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cells.极光激酶泛抑制剂达纳替尼可诱导人乳腺癌细胞凋亡和自噬,并抑制上皮-间质转化。
Drug Des Devel Ther. 2015 Feb 17;9:1027-62. doi: 10.2147/DDDT.S74412. eCollection 2015.
3
Danusertib Induces Apoptosis, Cell Cycle Arrest, and Autophagy but Inhibits Epithelial to Mesenchymal Transition Involving PI3K/Akt/mTOR Signaling Pathway in Human Ovarian Cancer Cells.达纳替尼诱导人卵巢癌细胞凋亡、细胞周期阻滞和自噬,但通过PI3K/Akt/mTOR信号通路抑制上皮-间质转化
Int J Mol Sci. 2015 Nov 13;16(11):27228-51. doi: 10.3390/ijms161126018.
4
Danusertib, a potent pan-Aurora kinase and ABL kinase inhibitor, induces cell cycle arrest and programmed cell death and inhibits epithelial to mesenchymal transition involving the PI3K/Akt/mTOR-mediated signaling pathway in human gastric cancer AGS and NCI-N78 cells.达努塞替布是一种强效的泛极光激酶和ABL激酶抑制剂,可诱导细胞周期停滞和程序性细胞死亡,并在人胃癌AGS和NCI-N78细胞中抑制涉及PI3K/Akt/mTOR介导的信号通路的上皮-间质转化。
Drug Des Devel Ther. 2015 Mar 2;9:1293-318. doi: 10.2147/DDDT.S74964. eCollection 2015.
5
Inhibition of Aurora kinases induces apoptosis and autophagy via AURKB/p70S6K/RPL15 axis in human leukemia cells.抑制 Aurora 激酶通过 AURKB/p70S6K/RPL15 轴诱导人白血病细胞凋亡和自噬。
Cancer Lett. 2016 Nov 28;382(2):215-230. doi: 10.1016/j.canlet.2016.08.016. Epub 2016 Sep 6.
6
Inhibition of Aurora A Kinase by Alisertib Induces Autophagy and Cell Cycle Arrest and Increases Chemosensitivity in Human Hepatocellular Carcinoma HepG2 Cells.阿利西替尼抑制极光激酶A可诱导人肝癌HepG2细胞自噬和细胞周期阻滞并增加化学敏感性。
Curr Cancer Drug Targets. 2017;17(4):386-401. doi: 10.2174/1568009616666160630182344.
7
The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.研究性极光激酶A抑制剂阿利西替尼(MLN8237)通过p38丝裂原活化蛋白激酶和Akt/哺乳动物雷帕霉素靶蛋白信号通路在人乳腺癌细胞中诱导细胞周期G2/M期阻滞、凋亡和自噬。
Drug Des Devel Ther. 2015 Mar 16;9:1627-52. doi: 10.2147/DDDT.S75378. eCollection 2015.
8
A quantitative proteomic response of hepatocellular carcinoma Hep3B cells to danusertib, a pan-Aurora kinase inhibitor.肝细胞癌Hep3B细胞对泛极光激酶抑制剂达努塞替布的定量蛋白质组学反应
J Cancer. 2018 May 24;9(12):2061-2071. doi: 10.7150/jca.20822. eCollection 2018.
9
A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.一种新型全反式维甲酸衍生物4-氨基-2-三氟甲基苯基维甲酸酯通过上调p53和ASPP1以及下调iASPP诱导G0/G1期细胞周期阻滞和凋亡,从而抑制人肝癌HepG2细胞的增殖。
Oncol Rep. 2016 Jul;36(1):333-41. doi: 10.3892/or.2016.4795. Epub 2016 May 9.
10
Investigation of prunetrin induced G2/M cell cycle arrest and apoptosis via Akt/mTOR/MAPK pathways in hepatocellular carcinoma cells.研究普那替尼通过 Akt/mTOR/MAPK 通路诱导肝癌细胞 G2/M 细胞周期阻滞和凋亡。
Biomed Pharmacother. 2024 May;174:116483. doi: 10.1016/j.biopha.2024.116483. Epub 2024 Mar 28.

引用本文的文献

1
A gene module identification algorithm and its applications to identify gene modules and key genes of hepatocellular carcinoma.基因模块识别算法及其在肝细胞癌基因模块和关键基因识别中的应用。
Sci Rep. 2021 Mar 9;11(1):5517. doi: 10.1038/s41598-021-84837-y.
2
Inhibition of vitamin D analog eldecalcitol on hepatoma and .维生素D类似物 eldecalcitol 对肝癌的抑制作用以及……(原文此处不完整)
Open Med (Wars). 2020 Jul 13;15(1):663-671. doi: 10.1515/med-2020-0137. eCollection 2020.
3
Resveratrol contributes to the inhibition of liver fibrosis by inducing autophagy via the microRNA‑20a‑mediated activation of the PTEN/PI3K/AKT signaling pathway.白藜芦醇通过 microRNA-20a 介导的 PTEN/PI3K/AKT 信号通路的激活诱导自噬,从而抑制肝纤维化。
Int J Mol Med. 2020 Dec;46(6):2035-2046. doi: 10.3892/ijmm.2020.4748. Epub 2020 Oct 9.
4
[Aurora kinase-B silencing promotes apoptosis of osteosarcoma 143B cells by ULK1 phosphorylation-induced autophagy].[极光激酶B沉默通过ULK1磷酸化诱导的自噬促进骨肉瘤143B细胞凋亡]
Nan Fang Yi Ke Da Xue Xue Bao. 2020 Sep 30;40(9):1273-1279. doi: 10.12122/j.issn.1673-4254.2020.09.08.

本文引用的文献

1
Systemic treatments for hepatocellular carcinoma: challenges and future perspectives.肝细胞癌的全身治疗:挑战与未来展望
Hepat Oncol. 2018 Feb 8;5(1):HEP01. doi: 10.2217/hep-2017-0020. eCollection 2018 Jan.
2
Ten years of sorafenib in hepatocellular carcinoma: Are there any predictive and/or prognostic markers?索拉非尼治疗肝细胞癌十年:是否存在任何预测和/或预后标志物?
World J Gastroenterol. 2018 Sep 28;24(36):4152-4163. doi: 10.3748/wjg.v24.i36.4152.
3
The functional diversity of Aurora kinases: a comprehensive review.极光激酶的功能多样性:全面综述
Cell Div. 2018 Sep 19;13:7. doi: 10.1186/s13008-018-0040-6. eCollection 2018.
4
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
5
The Expanding Role of Systemic Therapy in the Management of Hepatocellular Carcinoma.系统治疗在肝细胞癌管理中的扩展作用。
Can J Gastroenterol Hepatol. 2018 Aug 7;2018:4763832. doi: 10.1155/2018/4763832. eCollection 2018.
6
Molecular therapies and precision medicine for hepatocellular carcinoma.肝细胞癌的分子治疗和精准医学。
Nat Rev Clin Oncol. 2018 Oct;15(10):599-616. doi: 10.1038/s41571-018-0073-4.
7
Review article: systemic treatment of hepatocellular carcinoma.综述文章:肝细胞癌的系统治疗。
Aliment Pharmacol Ther. 2018 Sep;48(6):598-609. doi: 10.1111/apt.14913. Epub 2018 Jul 23.
8
Past, present, and future of Bcr-Abl inhibitors: from chemical development to clinical efficacy.Bcr-Abl 抑制剂的过去、现在和未来:从化学发展到临床疗效。
J Hematol Oncol. 2018 Jun 20;11(1):84. doi: 10.1186/s13045-018-0624-2.
9
Oral chemotherapy for the treatment of hepatocellular carcinoma.口服化疗药物治疗肝细胞癌。
Expert Opin Pharmacother. 2018 Jun;19(9):993-1001. doi: 10.1080/14656566.2018.1479398. Epub 2018 Jun 18.
10
Systemic therapy for intermediate and advanced hepatocellular carcinoma: Sorafenib and beyond.中晚期肝细胞癌的系统治疗:索拉非尼及其他药物。
Cancer Treat Rev. 2018 Jul;68:16-24. doi: 10.1016/j.ctrv.2018.05.006. Epub 2018 May 26.

达纳唑替尼对肝癌HepG2细胞周期、凋亡及自噬的影响

[Effect of danusertib on cell cycle, apoptosis and autophagy of hepatocellular carcinoma HepG2 cells ].

作者信息

Zhu Qiaohua, Luo Meihua, Zhou Chengyu, Chen Zhixian, Huang Wei, Huang Jiangyuan, Zhao Shufeng, Yu Xinfa

机构信息

Department of Oncology, Shunde Hospital of Southern Medical University, Shunde 528308, China.

出版信息

Nan Fang Yi Ke Da Xue Xue Bao. 2018 Dec 30;38(12):1476-1484. doi: 10.12122/j.issn.1673-4254.2018.12.13.

DOI:10.12122/j.issn.1673-4254.2018.12.13
PMID:30613017
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6744215/
Abstract

OBJECTIVE

To investigate the effect of danusertib (Danu), an inhibitor of Aurora kinase, on the proliferation, cell cycle, apoptosis, and autophagy of hepatocellular carcinoma HepG2 cells and explore the underlying mechanisms.

METHODS

MTT assay was used to examine the effect of Danu on the viability of HepG2 cells to determine the IC50 of Danu. The effect of Danu on cell cycle distribution, apoptosis and autophagy were determined using flow cytometry. Western blotting was used to detect the expressions of the proteins related to cell cycle, apoptosis and autophagy. Chloroquine was used to suppress Danuinduced autophagy to test the apoptosis-inducing effect of Danu.

RESULTS

Danu significantly inhibited the proliferation of HepG2 cells with IC of 39.4 μmol and 14.4 μmol at 24 h and 48 h, respectively. Danu caused cell cycle arrest in G/M phase in HepG2 cells and led to polyploidy accumulation via up-regulating the expressions of p53 and p21 and down-regulating the expressions of cyclin B1 and DC2. Danu also caused apoptosis of HepG2 cells through up-regulating the expressions of Bax, Puma, cleaved caspase-3, cleaved caspase-9, cleaved PARP and cytochrome C and down-regulating the expressions of Bcl-xl and Bcl-2. Danu induced autophagy via activating AMPK signaling and inhibiting PI3K/PTEN/AKT/mTOR axis, and inhibition of Danu-induced autophagy with chloroquine enhanced the pro-apoptotic effect of Danu.

CONCLUSIONS

Danu inhibits cell proliferation and induces cell cycle arrest in G/M phase, apoptosis and cytoprotective autophagy in HepG2 cells.

摘要

目的

研究极光激酶抑制剂达努昔布(Danu)对肝癌HepG2细胞增殖、细胞周期、凋亡及自噬的影响,并探讨其潜在机制。

方法

采用MTT法检测Danu对HepG2细胞活力的影响,以确定Danu的半数抑制浓度(IC50)。采用流式细胞术检测Danu对细胞周期分布、凋亡和自噬的影响。采用蛋白质印迹法检测与细胞周期、凋亡和自噬相关蛋白的表达。使用氯喹抑制Danu诱导的自噬,以检测Danu的促凋亡作用。

结果

Danu显著抑制HepG2细胞的增殖,在24小时和48小时时的IC50分别为39.4 μmol和14.4 μmol。Danu导致HepG2细胞的细胞周期阻滞于G/M期,并通过上调p53和p21的表达以及下调细胞周期蛋白B1和DC2的表达导致多倍体积累。Danu还通过上调Bax、Puma、裂解的半胱天冬酶-3、裂解的半胱天冬酶-9、裂解的聚(ADP-核糖)聚合酶和细胞色素C的表达以及下调Bcl-xl和Bcl-2的表达,导致HepG2细胞凋亡。Danu通过激活AMPK信号并抑制PI3K/PTEN/AKT/mTOR轴诱导自噬,用氯喹抑制Danu诱导的自噬增强了Danu的促凋亡作用。

结论

Danu抑制HepG2细胞的增殖,并诱导其细胞周期阻滞于G/M期、凋亡和细胞保护性自噬。